http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Park, Y.K.,Park, E.S.,Kim, D.H.,Ahn, S.H.,Park, S.H.,Lee, A.R.,Park, S.,Kang, H.S.,Lee, J.H.,Kim, J.M.,Lee, S.K.,Lim, K.H.,Isorce, N.,Tong, S.,Zoulim, F.,Kim, K.H. Elsevier Science Publishers 2016 Journal of hepatology Vol. No.
<P>Background & Aims: Cytokines are key molecules implicated in the defense against virus infection. Tumor necrosis factor-alpha (TNF-alpha) is well known to block the replication of hepatitis B virus (HBV). However, the molecular mechanism and the downstream effector molecules remain largely unknown. Methods: In this study, we investigated the antiviral effect and mechanism of p22-FLIP (FLICE-inhibitory protein) by ectopic expression in vitro and in vivo. In addition, to provide the biological relevance of our study, we examined that the p22-FLIP is involved in TNF-alpha-mediated suppression of HBV in primary human hepatocytes. Results: We found that p22-FLIP, a newly discovered c-FLIP cleavage product, inhibited HBV replication at the transcriptional level in both hepatoma cells and primary human hepatocytes, and that c-FLIP conversion to p22-FLIP was stimulated by the TNF-alpha/NF-kappa B pathway. p22-FLIP inhibited HBV replication through the upregulation of HNF3 beta but downregulation of HNF4 alpha, thus inhibiting both HBV enhancer elements. Finally, p22-FLIP potently inhibited HBV DNA replication in a mouse model of HBV replication. Conclusions: Taken together, these findings suggest that the anti-apoptotic p22-FLIP serves a novel function of inhibiting HBV transcription, and mediates the antiviral effect of TNF-a against HBV replication. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</P>